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ABSTRACT
Methylation of the cytosine is the most frequent
epigenetic modification of DNA in mammalian cells.
In humans, most of the methylated cytosines
are found in CpG-rich sequences within tandem
and interspersed repeats that make up to 45% of the
human genome, being Alu repeats the most common
family. Demethylation of Alu elements occurs in
aging and cancer processes and has been asso-
ciated with gene reactivation and genomic instabil-
ity. By targeting the unmethylated SmaI site within
the Alu sequence as a surrogate marker, we have
quantified and identified unmethylated Alu elements
on the genomic scale. Normal colon epithelial cells
contain in average 2548610157 unmethylated
Alu’s per haploid genome, while in tumor cells this
figure is 4199517187 (P=0.004). There is an
inverse relationship in Alu families with respect to
their age and methylation status: the youngest
elements exhibit the highest prevalence of the SmaI
site (AluY: 42%; AluS: 18%, AluJ: 5%) but the lower
rates of unmethylation (AluY: 1.65%; AluS: 3.1%,
AluJ: 12%). Data are consistent with a stronger
silencing pressure on the youngest repetitive ele-
ments, which are closer to genes. Further insights
into the functional implications of atypical unmethy-
lation states in Alu elements will surely contribute
to decipher genomic organization and gene regula-
tion in complex organisms.
INTRODUCTION
Progress in large-scale sequencing projects is critical to
identify and decipher gene organization and regulation in
many species including human. Nevertheless, cumulated
evidences indicate that the complexity of living organisms
is not just a direct outcome of the number of coding
sequences and that the presence of multiple regulatory
mechanisms accounts for a signiﬁcant part of biological
complexity (1,2). Among these mechanisms, repetitive
elements may play a key role in gene regulation and geno-
mic structure. Active transposable elements are involved
in genome rearrangement and illegitimate recombination
and can also inﬂuence gene expression by altering splicing
or by acting as enhancers or promoters (3–7). Advances in
the understanding of epigenetic mechanisms that regulate
these repetitive elements may contribute to elucidate their
speciﬁc participation in biological processes (8).
Silenced regions in mammals and other vertebrates are
diﬀerentiated, although not exclusively, by the presence
of DNA methylation (9). Methylation of the cytosine is
an epigenetic modiﬁcation of DNA that plays an impor-
tant role in the control of gene expression and chromo-
some structure in mammalian cells (10–13). Most of the
5-methylcytosines are found in CpG-rich sequences within
tandem and interspersed repeats (9,12) of which the
previous estimates indicate that constitute up to 45% of
the human genome (14). Among these repeats, Alu’s, with
more than one million copies per haploid genome, are
considered the most successful family (15). Interestingly,
Alu’s are not randomly distributed within the human
genome, as they tend to accumulate in gene-rich regions
(14,16,17). Previous works have estimated that Alu ele-
ments harbor up to 33% of the total number of CpG sites
in the genome (18) and have been reported to be highly
methylated in most somatic tissues (18–20). Methylation
represents the primary mechanism of transposon suppres-
sion and active transposons are demethylated in mamma-
lian genomes (12). It has been proposed that regions of the
genome containing repetitive elements might be masked
by compartmentalization of the chromatin, resulting in
a reduction of the eﬀective size of the genome (21).
Noteworthy,eventhoughavastnumberofCpGdinucle-
otides are provided by the collection of repetitive sequences
in the human genome, this dinucleotide is greatly under-
represented throughout the genome, but it can be found
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(200bp to a few kb), known as CpG islands (22). These
areas are ‘protected’ from methylation and are located
in the proximal promoter regions of 75% of human genes
(12,13,22). Methylated CpG islands are strongly and
hereditably repressed (12). Hence DNA methylation is
usually considered as a sign of long-term inactivation
(9,10,12).
Cancer cells are characterized by the accumulation of
both genetic and epigenetic changes. Widespread genomic
hypomethylation is an early alteration in carcinogenesis
and has been associated with genomic disruption and
genetic instability (23–27). Repeats unmasked by demeth-
ylation are likely to facilitate rearrangements due to mito-
tic recombination and unwanted transcription (28–30).
Alternatively, aberrant de novo methylation of CpG
islands is a hallmark of human cancers and is associated
with epigenetic silencing of multiple tumor suppressor
genes (31–37). Therefore, the screening for diﬀerentially
methylated sequences in tumors appears as a key tool
to further understand the molecular mechanisms under-
lying malignant transformation of cells. Although, the
repertoire of methylation screening methodologies has
expanded widely (37–39), and diﬀerent approaches have
been used to make bulk estimates of methylation in
repetitive elements (40,41), there is still a lack of screening
strategies that speciﬁcally allow a feasible identiﬁcation of
DNA methylation alterations in repetitive elements (21).
Here we report two variants of a novel methodology
to quantify and identify unmethylated Alu sequences.
The CpG site within the consensus Alu sequence AACCC
GGG is used as a surrogate reporter of methylation.
Unmethylated sites are cut with the methylation-sensitive
restriction endonuclease SmaI (CCCGGG) and an adap-
tor is ligated to the DNA ends. Quantiﬁcation of
UnMethylated Alus (QUMA) is performed by real-time
ampliﬁcation of the digested and adaptor-ligated DNA
using an Alu consensus primer that anneals upstream
of the SmaI site and an adaptor primer extended with the
TT dinucleotide in its 30 end (Figure 1A). The product
generated by this approach is completely inside the
Alu element and hence it is not possible to make a
unique identiﬁcation. As an alternative approach, we have
also performed restrained ampliﬁcation of digested and
adaptor-ligated DNA fragments that are ﬂanked by two
close SmaI sites. In this case, the same primer homologous
to the adaptor with the additional TT nucleotides at the
30 end to enrich for Alu sequences is used in absence of the
Alu consensus primer (Figure 1B). This second approach
is named Ampliﬁcation of UnMethylated Alu’s (AUMA)
and results in a complex representation of unique DNA
sequences ﬂanked by two unmethylated SmaI sites. When
resolved by high-resolution electrophoresis, the AUMA
generated sequences appear as a ﬁngerprint characteristic
of each sample (Figure 2) and individual scoring and
identiﬁcation of each band can be performed. Because
AUMA’s stringency is based on a short sequence
(AACCCGGG) that is found preferentially but not exclu-
sively in Alu elements, other unmethylated sequences are
also present in AUMA ﬁngerprints.
Application of QUMA and AUMA to a series of colo-
rectal carcinomas and their paired normal mucosa has
oﬀered global estimates of unmethylation of Alu elements
in normal and cancer cells and has revealed a large collec-
tion of unique sequences that undergo highly recurrent
hypomethylation and hypermethylation in colorectal
tumors.
MATERIALS AND METHODS
Tissuesand cell lines
Fifty colorectal carcinomas and their paired non-
adjacent areas of normal colonic mucosa were included
Figure 1. Schematic diagram of the QUMA and AUMA methods. DNA
is depicted by a solid line, Alu elements are represented by dashed boxes.
The QUMA and AUMA recognition sites (AACCCGGG) are repre-
sented by dashed/gray boxes. CpGs at SmaI sites are shown as full circles
when methylated and as open circles when unmethylated. The methyla-
tion-sensitive restriction endonuclease SmaI can only digest unmethylated
targets, leaving blunt ends to which adaptors can beligated. (A) QUMA is
performed by real-time PCR of an inner Alu fragment using a primer
complementary to the Alu consensus sequence upstream of the SmaI site
and the primer complementary to the adaptor to which two Alu
homologous nucleotides (TT) have been added. (B) In AUMA, sequences
ﬂanked by two ligated adaptors are ampliﬁed by PCR using a single
primer,thesameadaptorprimer plustheTTnucleotides.Whenonlyafew
nucleotides are added to the primer, i.e. TT, as illustrated here, other non-
Alu sequences may be ampliﬁed. This allows the ampliﬁcation of a large
number of sequences that typically range from 100 to 2000bp.
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fresh specimens and snap-frozen within 2h of removal and
then stored at  808C. All samples were obtained from the
Ciutat Sanita ` ria i Universita ` ria de Bellvitge (Barcelona,
Spain). The study protocol was approved by the Ethics
Committee. Human colon cancer cell lines (HT29, SW480,
HCT116, LoVo, DLD-1, CaCo-2 and LS174T) were
obtained from the American Type Culture Collection
(ATCC; Manassas, VA). KM12C and KM12SM cells were
generously provided by A. Fabra. DNA from tumor–
normal pairs was obtained by conventional organic extrac-
tion and ethanol precipitation. DNA purity and quality
was checked in a 0.8% agarose gel electrophoresis. RNA
from cell lines was obtained by phenol–chloroform
extraction and ethanol precipitation, following standard
procedures.
Bioinformatic analysis
The distribution of SmaI sites, putative ampliﬁcation hits,
PCR homologies, CpG islands and repetitive elements
was assessed using the human genome assembly 36.1 from
NCBI. Data were obtained from the Repbase (http://
www.girinst.org/repbase/index.html) and the Genome
Browser Databases (http://hgdownload.cse.ucsc.edu/
goldenPath/hg18/database/). Only assembled chromo-
some fragments were considered. A Perl routine was
used to score all positions containing the target sequences
in all chromosomes (available from the authors upon
request). Data were analyzed using Excel spreadsheets.
To calculate the proportion of unmethylated Alu
elements at the genomic level, the number of AUMA
hits identiﬁed in bioinformatic analysis were corrected
according to the distribution of experimentally generated
AUMA products performing Monte Carlo simulations.
One thousand Monte Carlo simulations were performed
using an Excel Add-in (available at www.wabash.edu/
econometrics). In Monte Carlo simulations, it was
assumed that 80–100% of SmaI sites at CpG islands are
unmethylated and that 50–100% of SmaI sites in other
genomic regions diﬀerent from Alu’s and CpG islands
are unmethylated.
Quantification ofQUMA
One microgram of DNA was digested with 20U of
the methylation sensitive restriction endonuclease
SmaI (Roche Diagnostics GmbH, Mannheim, Germany)
for 16h at 308C, leaving cleaved fragments with blunt
ends (CCC/GGG). Adaptors were prepared incubating
the oligonucleotides Blue (CCGAATTCGCAAAGCTC
TGA) and the 50 phosphorylated MCF oligonucleotide
(TCAGAGCTTTGCGAAT) at 658C for 2min, and then
cooling to room temperature for 30–60min. One micro-
gram of the digested DNA was ligated to 2nmol of
adaptor using T4 DNA ligase (New England Biolabs,
Beverly, MA, USA). Subsequent digestion of the ligated
products with the methylation insensitive restriction
endonuclease XmaI (New England Biolabs) was per-
formed to avoid ampliﬁcations from non-digested methy-
lated Alu’s. The products were puriﬁed using the GFX
Kit (Amersham Biosciences, Buckinghamshire, UK) and
eluted in 250ml of sterile water.
Quantitative real-time PCR was performed using 1ng
(the equivalent of 333 genomes) of DNA in a LightCycler
480 real-time PCR system with Fast Start Master SYBR
Green I kit (Roche). Mastermix was prepared to a ﬁnal
concentration of 3.5mM MgCl2 and 1mM of each primer.
The downstream BAu-TT primer (constituted by the 30
end of Blue primer, and the GGGTT sequence including
the GGG 30 side of the cut SmaI site and the Alu
homologous TT dinucleotide, ATTCGCAAAGCTCTG
AGGGTT) and the upstream primer was an Alu
consensus sequence (CCGTCTCTACTAAAAATACA)
(see Supplementary Data). Magnitudes were expressed
as number of unmethylated Alus per haploid genome
after DNA input normalization. The number of haploid
genomes present in the test tube was determined in the
same multiwell plate by quantiﬁcation of Alu sequences
irrespectively of the methylation state. A real-time PCR
using Alu consensus primers upstream of the CCCGGG
site was performed (see Supplementary Data) and the
number of genomes was calculated against a standard
curve constructed with a reference genomic DNA mea-
sured by UV spectrophotometry.
To determine the eﬃciency of the assay and to perform
absolute quantiﬁcation, an external Alu product generated
by PCR from a DNA fragment containing an AluSx
element was used as standard (Supplementary Methods).
The number of copies of the external control were spectro-
photometrically quantiﬁed and dilution curves were gene-
rated and treated as samples. Comparison of dilution
curves before and after sample processing indicated that
the mean recovery was 73%. DNA samples overdigested
Figure 2. AUMA of normal (N)–tumor (T) pairs of two diﬀerent
patients performed using primer BAu-TT. A highly reproducible band
patterning is observed among the four replicates. Representative bands
showing gains (hypomethylations) and losses (hypermethylations) are
marked with up and down arrowheads, respectively.
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spiked with diﬀerent amounts of the external standard and
processed. The sensitivity of the QUMA detection was 100
unmethylated Alu’s per haploid genome (Supplementary
Figure 1) using 1ng of genomic DNA per PCR. A linear
response wasobserved between 1000and100000 unmethy-
lated Alu’s per haploid genome (Supplementary Data).
Amplification ofAUMA
DNAdigestionwithSmaIenzymeandligationtothelinker
was performed as described above for QUMA, except for
the XmaI digestion that was skipped. The product was
puriﬁed using the GFX Kit (Amersham Biosciences) and
eluted in 250ml of sterile water. Six diﬀerent chimeric
primers constituted by the 30 end of the Blue primer
sequence (ATTCGCAAAGCTCTGA), the cut SmaI site
(GGG) and two, four or seven additional nucleotides
homologous to the Alu consensus sequence were used to
enrich for Alu sequences (see Supplementary Methods).
Three primers were designed to amplify ‘upstream’ of the
SmaIsite(towardsALUpromoter):BAu-TT,BAu-TTCA,
BAu-TTCAAGC. Three other primers were designed to
amplify ‘downstream’ (towards ALU poly-A): BAd-AG,
BAd-AGGC, BAd-AGGCGGA. Letters after the dash
correspond to the 30 sequence of the primer (see Supple-
mentary Data). Data reported here were obtained by using
the BAu-TT primer.
In each PCR reaction only one primer was used at
a time. Products were resolved on denaturing sequencing
gels. Although bands can be visualized by silver staining
of the gels, radioactive AUMA’s were performed for
normal–tumor comparisons. A more detailed description
of the PCR and the visualization of the bands are given
as Supplementary Data.
Only sharp bands that were reproducible and clearly
distinguishable from the background were tagged and
included in the analysis. Faint bands with inconsistent
display due to small variations in gel electrophoresis
resolution were not considered. Band reproducibility was
assessed with the analysis of PCR duplicates of three
independent sample digests from two diﬀerent samples
and PCR replicates from the same digest from four paired
tumor–normal samples. AUMA ﬁngerprints were visually
checked for methylation diﬀerences between bands in the
tumor with regard to its paired normal mucosa. Under
these premises, a given band was scored according to three
possible behaviors: hypomethylation (increased intensity
in the tumor), hypermethylation (decreased intensity in
the tumor) and no change (no substantial diﬀerence in
intensity between normal and tumor samples) (Figure 2).
Only those bands showing clear changes in their intensities
in the ﬁngerprint were considered to represent methylation
changes. This is consistent with previous studies done
using a related technique (42,43).
Competitive hybridization ofAUMA productsto metaphase
chromosomes andBAC arrays
The origin and chromosomal distribution of sequences
generated by AUMA was analyzed using procedures
analogous to CGH. Brieﬂy, an AUMA product obtained
from a normal tissue DNA was puriﬁed using Jet quick
PCR product puriﬁcation kit (Genomed, Lo ¨ hne,
Germany) and labeled with SpectrumRed dUTP (Vysis,
Downers Grove, IL, USA) using a Nick Translation kit
(Vysis). Similarly, genomic DNA of the same normal
sample was labeled with SpectrumGreen dUTP (Vysis)
and both probes were cohybridized to metaphase chromo-
somes. Procedures and image analysis were performed as
described (44).
Diﬀerential normal–tumor representation of AUMA
at the genomic scale was performed by competitive
hybridization of AUMA products to BAC arrays.
AUMA products from two normal–tumor pairs were
puriﬁed using Jet quick PCR product puriﬁcation kit
(Genomed, Lo ¨ hne, Germany) and 1mg was labeled with
dCTP-Cy3 or dCTP-Cy5 (Amersham Biosciences, UK) by
use of the Bioprime DNA Labeling System (Invitrogen,
Carlsbad, CA, USA). Probes were hybridized to Spectral-
Chip 2600 BAC arrays (Spectral Genomics, Houston, TX,
USA) following the manufacturer’s instructions. Arrays
were scanned with a ScanArray 4000 (GSI Lumonics,
Watertown, MA, USA) and processed with GenePix
software (Axon Instruments, Union City, CA, USA). The
resulting data were processed to ﬁlter out low-quality
spots based on spot area and similarity of readings
between the two replicates of each BAC. Data manipula-
tion was performed using Excel spreadsheets. Because
AUMA products are not evenly distributed along chro-
mosomes, only BACs with intensities above the 10% of
maximum intensity in at least one of the two channels
were considered for ratio calculations. The pattern of
chromosomal alterations in these two tumors was deter-
mined by conventional CGH as described (44).
Isolationand cloning ofAUMA tagged bands
DNA excised from gels was directly ampliﬁed with the
same primer used in AUMA (BAu-TT) (Supplementary
Figure 2). The ampliﬁed product was cloned into plasmid
vectors using the pGEM-T easy vector System I cloning
kit (Promega, Madison, WI, USA). Automated sequenc-
ing of multiple colonies was performed using the Big Dye
Terminator v3.1 Cycle Sequencing kit (Applied Biosys-
tems, Foster City, CA, USA) to ascertain the unique
identity of the isolated band. Sequence homologies were
searched for using the Blat engine (http://genome.ucsc.
edu/). Selected clones corresponding to AUMA isolated
bands were radioactively labeled and used as a probe to
conﬁrm the identity of the excised band by hybridization
to AUMA ﬁngerprints as previously described (45).
Bisulfite genomic sequencing
Diﬀerential methylation observed in some AUMA
tagged bands was conﬁrmed by direct sequencing of
bisulﬁte treated normal and tumor DNA as previously
described (46). Prior to sequencing, DNA was ampliﬁed
using a nested or semi-nested PCR approach, as appro-
priate. Three independent PCRs were done and products
were pooled to ensure a representative sequencing.
Nucleic Acids Research,2008, Vol. 36,No. 3 773The sequence of PCR primers is described in
Supplementary Data.
Histone modification analysis by chromatin
immunoprecipitation (ChIP)
Brieﬂy, 6 10
6 cells were washed twice with PBS andcross-
linked on the culture plate for 15min at room temperature
in the presence of 0.5% formaldehyde. Cross-linking
reaction was stopped by adding 0.125M glycine. All subse-
quent steps were carried out at 48C. All buﬀers were pre-
chilled and contained protease inhibitors (Complete Mini,
Roche). Cells were washed twice with PBS and then
scraped. Collected pellets were dissolved in 1ml lysis buﬀer
(1% SDS, 5mM EDTA, 50mM Tris pH 8) and were
sonicated in a cold ethanol bath for 10 cycles at 100%
amplitude using a UP50H sonicator (Hielscher, Teltow,
Germany). Chromatin fragmentation was visualized in 1%
agarose gel. Obtained fragments were in the 200–500pb
range. Soluble chromatin was obtained by centrifuging the
sonicated samples at 14000g for 10min at 48C. The soluble
fraction was diluted 1/10 in dilution buﬀer (1% Triton
X-100, 2mM EDTA, 20mM Tris pH 8, 150mM NaCl)
then aliquoted and stored at  808C until use.
Immunoprecipitation was carried out at 48C by adding
5–10mg of the desired antibody to 1ml of chromatin.
Chromatin–antibody complexes were immunoprecipitated
with speciﬁc antibodies using a protein A/G 50% slurry
(Upstate, Millipore, Billerica, MA, USA) and subse-
quently washed and eluted according to the manufac-
turer’s instructions. Antibodies against acetylated H3
K9/K14 (Upstate), dimethylated H3 K79 and trimethyl-
ated H3 K9 (Abcam, Cambridge, UK) were used. Enrich-
ment for a given chromatin modiﬁcation was quantiﬁed as
a fold enrichment over the input using quantitative real-
time PCR (Roche). For every PCR, a standard curve was
obtained to assess ampliﬁcation eﬃciency. All quantiﬁca-
tions were performed in duplicate.
RESULTS
Genomic estimation of the targetsand evaluation ofthe
adequacy of theapproach by computational analysis
The availability of the human genome map has allowed
us to make a detailed estimation of the frequency and
distribution of the sites targeted by our approaches on
the genomic scale. A Perl routine was used to score all
positions containing the target sequences in all chromo-
somes and was also applied to perform a virtual AUMA
(see Material and Methods section). Some of the most
important data derived from the bioinformatic analysis
are shown in Table 1 and Figure 3.
Because of the C to T mutational bias at CpG sites (47),
any ampliﬁcation method relying on the consensus
sequence (see Supplementary Data) will only cover a
fraction of all the Alu’s. Therefore it is important to
estimate the degree of representativity of the methods
used here if genome-wide estimations are to be made. Alu
repeats constitute 7.4% of the human genome but accu-
mulate 40.7% of all SmaI sites (Table 1). Nearly 200000
Alu’s (18% of all Alu’s) contain a SmaI site and 155000
retain the AACCCGGG consensus sequence (Table 1 and
Figure 3) and are therefore potential targets of QUMA
and AUMA. While 38.0% of the youngest AluY elements
contain this sequence, the proportions drop to 14.8 and
0.4% in AluS and AluJ families, respectively (Table 1 and
Figure 3). These frequencies are consistent with a higher C
to T transition trend at CpG sites in older Alu’s (47).
The representativity of AUMA was analyzed by a
virtual bioinformatic assay of the human genome
sequence. A total of 168309 AACCCGGG (or CCCGG
GTT) hits were identiﬁed throughout the genome, with
92.9% of all hits within Alu elements (Table 1 and
Figure 3). This implies that 14.2% of all Alu elements
contained the AACCCGGG sequence. Another 1.0% of
the hits were in CpG islands and 6.8% in the rest of the
genome (including unique sequences and other repeats)
(Table 1 and Figure 3). As expected, Alu elements con-
taining the target sequence mostly belonged to the AluS
Table 1. Content and distribution of QUMA and AUMA hits in the human genome
Sequence Mb
a Number of
elements
b
SmaI sites
(CCCGGG)
AACCCGGG
hits
c
Virtual
AUMA hits
d
AUMA
hits
e
Unmethylated
hits
f
Unmethylated
hits (%)
g
Total 3080.4 1118195 486835 168309 5498 201 14332 2418 8.52 1.4%
Alu (S+J+Y) 227.3 1091110 198201 155226 5109 59 (29.3%) 4104 688 2.64 0.44%
AluS 141.2 660415 122459 97951 3382 45 (22.4%) 3028 510 3.09 0.51%
AluJ 54.0 283104 14017 1235 38 2 (1.0%) 151 25 12.25 1.97%
AluY 32.1 147591 61725 56040 1689 12 (6.0%) 925 156 1.65 0.27%
CpG islands 16.2 27085 49430 1673 63 55 (27.4%) 1501 97 90.5 5.79%
Rest 2836.9 – 239204 11410 326 87 (43.3%) 8530 1650 75.9 14.63%
aGenome Mb represented by each type of element. Total number corresponds to the number of megabases analyzed for the presence of hits.
Only assembled chromosome fragments were considered.
bElements considered in the analysis as obtained from the Repbase and the Genome Browser Databases (see Material and Methods section).
cNumber of occurrences of the sequence AACCCGGG (or CCCGGGTT) within each type of element.
dNumber of AUMA hits present in virtual PCR products of up to 1000bp.
eHits of actual AUMA products. Only bands appearing in normal tissue were considered. Eighty-seven bands contributed two hits each (174 hits)
and 27 bands contributed only one due to poor sequence or incomplete homology with the NCBI Build 36.1 of the human genome (hg18 assembly,
March 2006). Twenty-three additional bands were detected mainly in tumor tissue and were not considered to perform calculations.
fEstimated number of unmethylated sites using Monte Carlo simulations (Material and Methods section).
gIn respect to the total number of AACCCGGG (or CCCGGGTT) hits.
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tion of the older family AluJ (<1%). Virtual AUMA
determined the presence of 5498 putative products of
<1Kb (the sequence AACCCGGG in the up strand and
the sequence CCCGGGTT in the down strand at a
distance of <1kb). Although actual AUMA PCR
products may reach 2kb length (see below), we used the
1kb limit to compare with AUMA-isolated bands, which
were shorter than 1kb. Most virtual AUMA products
contained an Alu element at one of the ends at least
(93%).
Quantification of unmethylated Alu in normal
and tumortissues
The QUMA approach was applied to quantify unmethy-
lated Alu’s in a series of 18 colorectal carcinomas and their
paired normal colonic mucosa. An external DNA frag-
ment containing an AluSx element was used as a standard
(see Materials and Methods section and Supplementary
Data) in order to make an absolute quantiﬁcation of the
number of unmethylated Alu’s. Replicates and dilution
curves of the samples and standard were performed
to assess reproducibility, sensitivity and accuracy
(Supplementary Figure 1). Results were normalized by
assessment of the number of haploid genomes per test tube
(see Material and Methods section). The average number
of unmethylated Alu’s per haploid genome was
25486 10157 in normal mucosa, and 41995 17187
in tumor samples (P=0.004, paired t-test) (Figure 4).
We computationally identiﬁed a total of 168309 Alu
elements containing the AACCCGGG sequence (potential
targets of QUMA) (Table 1). Therefore we estimate
that 15.1% of Alu repeats with a AACCCGGG site are
unmethylated in the average normal colonic mucosa cell,
while this ﬁgure is 24.9% in the cancer cell. Considering
that the human genome contains  1.1 million Alu ele-
ments, these estimates indicate that unmethylated Alu’s
constitute the 2.3 and 3.8% of all Alu’s in the normal and
tumor tissues, respectively.
Set-up andoptimization of AUMA fingerprinting
Because QUMA products are fully contained within the
Alu sequence, it is not possible to identify and position
in the genome the unmethylated Alu elements. To achieve
this it is necessary to amplify the targeted unmethylated
Alu element together with an adjacent unique sequence.
This was attained through the use of the second method,
the Ampliﬁcation of UnMethylated Alus (AUMA).
AUMA also targets the unmethylated AACCCGGG
sequence, as in QUMA, but in this case a single primer
is used in the PCR (BAu-TT) (see Figure 1 and Supple-
mentary Data). Moreover, the product is resolved on
a high-resolution gel electrophoresis resulting in a band-
rich ﬁngerprint. AUMA bands correspond to sequences
ﬂanked by two unmethylated target sequences in opposite
strands and suﬃciently close to allow PCR ampliﬁcation
(Figure 1 and Supplementary Data). Since 92% of the
AACCCGGG occurrences in the human genome are in
Alu’s (Table 1), the approach is largely biased towards
the ampliﬁcation of unmethylated Alu’s. The presence
of non-Alu sequences at one of the ends or between two
repetitive elements allows the positioning within the
genome map of all products.
AUMA products generated using the BAu-TT primer
produced highly reproducible ﬁngerprints consisting of
bands ranging from  100 to  2000bp when resolved in
high-resolution sequencing gels (Figure 2 and Supplemen-
tary Figure 2). Some well-identiﬁable bands (up to 5 per
experiment) showed random display in both intra-assay
and inter-assay replicates (Supplementary Figure 2) and
were not considered for analysis. A subset of 110 bands
with consistent display among all the experiments were
tagged and selected for comparative analysis between
samples (see Materials and Methods section).
It should be noted that diﬀerent ﬁngerprints containing
alternative representations may be obtained by AUMA
Figure 3. Relative distribution the Alu elements and sequence targets
considered in bioinformatic and experimental QUMA and AUMA.
Mb: number of megabases occupied by each type of element; elements:
number of elements considered (‘Rest’ has been set arbitrarily to 50%);
SmaI site: CCCGGG sequence; vQUMA hits: AACCCGGG (or GGG
CCCTT) sites in Alu elements; vAUMA hits: AACCCGGG (or GGGC
CCTT) sites; vAUMA ends: vAUMA hits considering only putative
AUMA products of <1kb (see Material and Methods section);
AUMA: elements at each one of the two ends of actual AUMA
products.
Figure 4. Quantitation of unmethylated Alu’s in 17 paired normal
mucosa and colorectal carcinoma by QUMA. The values represent the
estimated number of unmethylated Alu’s per haploid genome. Most
tumors exhibited a higher level of hypomethylation when compared
with the respective normal.
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site towards the Alu promoter (upstream Alu ampliﬁca-
tion) or towards the Alu poly-A tail (downstream Alu
ampliﬁcation). Also the stringency of the Alu selection
may be increased by using longer primers containing
additional nucleotides corresponding to the Alu consensus
sequence (see Material and Methods section). An illus-
trative example of AUMA ﬁngerprints generated with
diﬀerent Alu-upstream and Alu-downstream primers is
shown in Supplementary Figure 2. All the data reported
in this article regarding AUMA were obtained using the
BAu-TT primer.
Chromosomalorigin of AUMA products
Competitive hybridization between AUMA products
and genomic DNA on metaphase chromosomes yielded
a characteristic hybridization pattern demonstrating
the unequal distribution of AUMA products along the
human genome (Figure 5A). Competitive hybridization of
AUMA products to BAC arrays showed proﬁles consis-
tent with those obtained on metaphase chromosomes
(Figure 5B). The highest AUMA signal was detected
in whole chromosomes 16, 17 and 19 in contrast with
chromosomes 2, 13, 18 and X which were mainly labeled
by genomic DNA. Other chromosomes showed a discrete
pattern of AUMA product hybridization, in which telo-
meric bands in chromosomes 1, 4, 5, 9, 12 and X, and
interstitial bands in chromosomes 1, 3, 7, 11 and 12 are the
most prominent examples.
Identification of AUMA amplified DNA products
To determine the identity of bands displayed by AUMA,
38 tagged bands were isolated and cloned. Multiple clones
from each band were sequenced, resulting in a total of
49 diﬀerent sequences due to the coincidence of more
than one sequence in some bands. Characterized bands
included bands displaying no changes in the normal–
tumor comparisons and bands recurrently altered in the
tumor. Table 2 summarizes the main features of a subset
of the bands showing recurrent alterations. A list of all the
sequences isolated from AUMA ﬁngerprints is provided
as Supplementary Table 1. All sequenced bands contained
a region of non-repetitive sequence and matched with the
BLAST reference sequence, allowing the assignment of
a unique chromosomal localization. The BLAST reference
sequence corresponding to the 49 sequences isolated from
the AUMA ﬁngerprint presented the target sequence
CCCGGGTT including the SmaI at both ends. Southern
blot analysis of selected cloned sequences showing coinci-
dental size was performed to conﬁrm its correspondence
with the band displayed in AUMA ﬁngerprints (Supple-
mentary Figure 4).
To obtain a more representative collection of AUMA
bands, 200 clones obtained from normal tissue AUMA
products were sequenced. The analysis revealed 88 addi-
tional sequences. This resulted in a total of 137 diﬀerent
loci represented in AUMA (Supplementary Table 1).
Most sequences obtained by random cloning were also
ﬂanked by two AACCCGGG sequences in opposite DNA
strands. Nevertheless, in 27 sequences the AACCCGGG
site was only present at one of the ends, with the other
end showing high homology with the primer although
it was not a perfect match. The presence of these
sequences suggests that, in some instances, a single cut
in the sequence may be enough to produce an ampliﬁable
fragment. This is not considered an artifact since these
bands still represent an unmethylated AACCCGGG site.
Genome-wide estimations ofunmethylation in Alu’s
and distribution by subfamily
Of the 137 identiﬁed loci represented in AUMA, 114 were
isolated from normal tissue DNA and 23 from tumor
DNA. Half of the sequences contained an Alu sequence at
one of the ends and two were ﬂanked by two inverted
Alu’s. AUMA sequences isolated from tumor tissue and
not present in normal tissue (this corresponds to a tumor-
speciﬁc hypomethylation) showed a higher proportion
of Alu elements (16 out of 23, 70%), and included one
sequence ﬂanked by two inverted Alu’s. Globally, 78
unmethylated Alu elements were identiﬁed and positioned
in the human genome map.
To study the genomic distribution of unmethylated
sequences in normal colon mucosa, we only considered the
114 sequences obtained from normal tissue. This resulted
in a total of 201 unmethylated hits characterized through-
out the genome. The nature of the sequences represented
in actual AUMA showed striking diﬀerences with the
distribution expected from the virtual AUMA analysis.
The methylation status of the sequence is likely to be the
main (if not the only) source of these diﬀerences because
the virtual AUMA did not consider this state. Therefore
we can use these diﬀerences to estimate the degree of
unmethylation of the Alu repeats. Only 29.4% of the
AUMA ends consisted of Alu’s, as compared with the
expected 92.9% resulting from the bioinformatic analysis.
The highest downrepresentation corresponded to the
youngest AluY family, which was present in 6.0% of the
AUMA ends, while it was expected to add up to 33.1% in
virtual AUMA. AluS representation in actual and virtual
AUMA was 22.3% and 60%, respectively. Interestingly,
AluJ representations, in both actual and virtual AUMA,
were closer (1.0% and 0.7%, respectively) (Figure 3 and
Table 1). These results suggest that there is a stronger
pressure to methylate younger Alus. Alternatively, the hits
corresponding to CpG islands were overrepresented in
actual versus virtual AUMA by a factor of nearly 25-fold
(27.4% versus 1.1%), consistently with the unmethylated
status of most CpG islands (Figure 3 and Table 1). The
rest of the hits were located in diﬀerent types of repetitive
elements (MIR, MER, LTR, LINE, etc.) and unique
sequences (Supplementary Table 1). The miscellaneous
collection of sequences (‘Rest’) was over-represented by
about 7-fold (observed hits: 43.3%; expected hits: 5.9%,
Table 1). The 46 AUMA hits represented by the 23 bands
speciﬁc of tumor tissue showed a higher proportion of
Alu’s compared with those obtained from normal tissue
(41% versus 29%, respectively), but similar distribution
776 Nucleic Acids Research, 2008, Vol. 36, No. 3Figure 5. (A) Chromosomal origin of AUMA products. A competitive hybridization of AUMA product obtained from normal tissue DNA (red) and
genomic DNA (green) to metaphase chromosomes was performed. AUMA products showed an unequal distribution along chromosomes, displaying
highest densities at most telomeric regions and some interstitial bands. Chromosomes 16, 17 and 19 yielded the highest AUMA density. (B) Intensity
distribution of AUMA products hybridized to BAC arrays in selected chromosomes. The average intensity (X-axis) of the two normal (blue) and
tumor samples analyzed (red) for each BAC is shown. BACs are arranged along the Y-axis according to its position in the chromosome.
(C) Diﬀerential methylation proﬁles determined by competitive hybridization of AUMA products from normal and tumor tissue to BAC arrays.
Illustrative examples are shown for chromosomes 7 and 8 from the two cases analyzed (81 and 151). X-axis indicates log2 ratio of tumor/normal
intensities. Positive values (to the right) indicate hypomethylations, negative values (to the left) indicate hypermethylations. Additional examples are
shown in Supplementary Figure 5.
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and 26 in other sequences).
To calculate the proportion and distribution of
unmethylated Alu elements on a genomic scale, we
performed Monte Carlo simulations taking into account
the observed and expected distribution of hits in each
Alu family and CpG islands and the rest of sequences
(see Material and Methods section). We estimate that
at least 4104 Alu elements are unmethylated or partially
unmethylated in normal colonic mucosa. This corresponds
to 2.64% of all Alu elements containing the target
sequence AACCCGGG (Table 1). Although AluS and
AluY represent the majority of these sequences it should
be noted that the methylation pressure is inverse to the
conservation of the SmaI site. That is, the most conserved
and younger AluY family shows the lowest relative rate
of unmethylation; and the older and more degenerated
AluJ family exhibits the highest unmethylation.
Application ofAUMA to detect differential DNA
methylation incolorectal carcinomas
In order to test the usefulness of the method for the
detection of new altered methylation targets, we applied
AUMA to a series of 50 colorectal carcinomas and their
paired normal mucosa. Two cases were excluded from
the analysis due to recurring experimental failure of the
normal or tumor tissue DNA. For the rest of 48 normal–
tumor pairs, consistent and fully readable ﬁngerprints
were generated and evaluated for normal–tumor diﬀer-
ential representation. A given case presented, on average,
107 2.9 informative bands (range 98–110). The variation
was due to polymorphic display or variable resolution
power of gel electrophoresis.
In this study, only those bands showing clear intensity
diﬀerences between normal and tumor tissue ﬁngerprints
(Figure 2) have been scored as methylation changes since
they are more likely to reﬂect tumor-wide alterations.
Because the ﬁngerprints represent sequences ﬂanked by
two unmethylated sites, a decreased intensity in a given
band in the tumor in regard to the paired normal tissue
is indicative of hypermethylation, while an increased
intensity corresponds to hypomethylation (Figure 2).
All tumors displayed changes in regard to the paired
normal tissue. The average tumor showed 19 7 (range
6–37) hypomethylations and 22 10 (range 1–39) hyper-
methylations. It is of note that hypomethylations could
eitherbeseenasanincreaseintheintensityofapre-existing
band in the normal tissue or as the appearance of an non-
existent band in the normal tissue. This contrasts with
hypermethylation events, which rarely showed the com-
plete loss of a band in the tumor sample, most likely due to
the unavoidable contamination of normal tissue.
Virtually, all tagged bands (109 out of 110) were found
to be altered in at least one tumor when compared to its
normal paired mucosa. AUMA tagged bands presented a
wide distribution in the hypomethylation/hypermethyla-
tion rates (proportion of tumors showing diﬀerential
display compared to the paired normal tissue) (Figure 6).
Hypomethylation and hypermethylation showed a strong
negative correlation (r= 0.55 and P<0.0001), indicat-
ing that most bands tended to be either hypomethylated
Table 2. A selection of characterized AUMA bands
Band ID Size
(bp)
% GC Chromosome map
(Location
a)
Gene CpG island
b Repetitive
elements in
band ends (50/30)
Methylation status
in tumor
c
Ai1 c3 509 55 17p11.2 (18206453–18206961) SHMT1 Yes Alu Sx/MIR Hypermethylated
Aj2 c1 458 49 1q32.2 (206389082–206389539) MGC29875 Yes Alu Sq/None Hypomethylated
Ao1 c4 365 50 19q13.32 (53550179–53550543) AK001784 No Alu Sx/MIRb Hypomethylated
Ap1 c6 358 56 5q35.2 (175157321–175157674) CPLX2 Yes None/MIR Hypermethylated
Aq3 c6 339 58 8p23.3 (2007343–2007682) MYOM2 No LTR/Alu Y Hypomethylated
Ar3 c3 329 57 2q14.3 (127875178–127875506) AF370412 Yes None/MIRb Hypomethylated
As3 c6 306 63 16p13.3 (3160477–3160782) None Yes None/None Hypermethylated
Au4 c1 268 57 16p13.3 (3162099–3162366) None No tRNA/None Hypermethylated
aNucleotide position within the contig (strand +). NCBI Build 36.1 of the human genome.
bThe whole sequence or a fragment of the sequence lays not further than 200bp of a predicted CpG island.
cAs compared to the paired normal tissue.
Figure 6. Distribution of hypermethylation and hypomethylation rates
in the 110 AUMA tagged bands. Rates were obtained by comparison
of the AUMA ﬁngerprints obtained in 50 colorectal tumors as
compared to their respective matched normal tissue.
778 Nucleic Acids Research, 2008, Vol. 36, No. 3or hypermethylated. A large proportion of tagged bands
(78 bands) were recurrently altered in over 25% of the
cases included in this series.
In order to determine whether normal–tumor diﬀerences
were limited to isolated independent loci or changes that
might aﬀect larger chromosomal regions, we compared the
distributionofAUMAproductsgeneratedfromtwopaired
normal and tumor tissues and hybridized to BAC arrays.
Diﬀerential hybridization was observed in many BACs,
suggesting that relatively large regions encompassing from
severalhundredKbstoafewMbsmayundergoconcurrent
hypomethylation or hypermethylation. Telomeric regions
of many chromosomes contained most of the diﬀerential
display (Figure 5C). The diﬀerential methylation proﬁles
were unaﬀected by chromosomal dosage as demonstrated
by its independence of chromosomal losses and gains (as
detected by Comparative Genomic Hybridization (CGH)
(Supplementary Figure 5).
Validation of methylation changes detected byAUMA
To conﬁrm that the changes observed in AUMA ﬁnger-
prints corresponded to actual changes in the methylation
status of the sequence, eight diﬀerent sequences obtained
from AUMA ﬁngerprints were analyzed in normal and
tumor tissues by direct sequencing of sodium bisulﬁte-
treated DNAs (Table 2). Moreover, it was demonstrated
that methylation changes aﬀected not only the CpG in at
least one of the two ﬂanking SmaI sites (whose methyla-
tion prevents AUMA representation) but also neighboring
CpGs (Supplementary Figure 6). In two samples, hyper-
methylations/hypomethylations detected by AUMA could
not be conﬁrmed by bisulﬁte sequencing, suggesting that
the change could aﬀect only a small fraction of tumor cells
and that both methods may exhibit diﬀerent sensitivities.
The presence of minor subpopulations can be detected
using more sensitive techniques, i.e. the Methylation
Speciﬁc PCR or by sequencing of multiples clones.
Functional implications of changes detectedby AUMA
Next, we wondered if DNA methylation changes detected
by AUMA may have any functional consequences. We
chose one of the most recurrent hypomethylated AUMA
sequences (Aq3) and performed an insightful epigenetic
characterization of the region in a series of normal–tumor
pairs and in colon cancer cell lines.
Aq3 band is recurrently hypomethylated in tumors
according to AUMA ﬁngerprints (Figure 7A). It repre-
sents a sequence situated in the eighth intron of the
MYOM2 gene (Table 2) and does not fall inside or close to
any CpG island. The SmaI sites are located in a MLT1A
repeat and an AluYd3 element. The methylation status the
two ﬂanking regions of the AUMA band (465bp and
213bp long spanning 20 and 11 CpGs, respectively) was
analyzed by bisulﬁte direct sequencing (Figure 7B).
Conﬁrmation of AUMA data was performed in three
normal–tumor pairs exhibiting diﬀerential display of the
Aq3 band in AUMA ﬁngerprints (cases 17, 63 and 74)
and two cases lacking this band in both normal and tumor
pair (cases 53 and 99) (Figure 7A), as well as ﬁve cell lines
(HCT116, DLD-1, LoVo, HT29 and CaCo2). All normal
tissues as well as tumors 53 and 99 showed heavy methy-
lation of this region (Figure 7C). In contrast to this and
in agreement with AUMA results, tumors 17, 63 and
74 exhibited hypomethylation at most CpGs. Cell lines
showed variable proﬁles of DNA methylation, with
CaCo2 exhibiting unmethylation of the MLT1A element
but heavy methylation of the AluYd3 element, which
was also heavily methylated in HCT116 cells but not in the
rest of the cell lines tested. MYOM2 expression levels
analyzed by real-time RT-PCR were not aﬀected by the
methylation status of this sequence (data not shown).
Further 45 normal–tumor pairs were analyzed for methy-
lation of the AluYd3 element by real-time dissociation
analysis (Supplementary Figure 7) and it was found
hypomethylated in 26 tumors (58%).
Next, we wondered whether the DNA methylation
status of the AluYd3 element was associated with alter-
native chromatin states. We performed Chromatin
ImmunoPrecipitation (ChIP) analysis of histone 3 (H3)
modiﬁcations indicative of active chromatin: acetylation
of lysines 9 and 14 (AcH3K9/K14), and dimethylation
of lysine 79 (2mH3K79); and silent chromatin: trimethy-
lation of lysine 9 (3mH3K9). These histone marks were
compared between cell lines HCT116 and LoVo (with
100% and 30% methylation of the AluY element, respec-
tively). The silencing mark 3mH3K9 was 3.5-fold higher in
HCT116 cells compared to the LoVo cell line (Figure 7D).
No diﬀerences in active marks were observed and these
were signiﬁcantly lower than the silencing mark 3mH3K9.
When HCT116 cells were treated with the demethy-
lating agent 5-aza-20-deoxycytidine (5AzaC) and the
inhibitor of histone deacetylase trichostatin A (TSA),
a moderate decrease in the amount of the 3mH3K9 mark
was observed (Figure 7E). As a whole, these data suggest
that DNA methylation changes in this AluYd3 element
are accompanied by alternated chromatin states. The
molecular consequences of such epigenetic changes remain
to be identiﬁed.
DISCUSSION
Epigenetic statesof Alu elements
Full genome sequencing has provided precise maps
of repetitive elements, and several studies have investigated
their distribution and relationship with genome structure
(48–51). More recently, a few studies have explored
sequence-dependent associations between repetitive ele-
ments and the epigenetic landscape. There is a character-
istic distribution of interspersed elements along methylated
and unmethylated domains, with most elements in the
methylated compartment of the genome (21). Nevertheless,
SINEs, which include Alu elements, are the repetitive
sequencesmostcommonlyfound inunmethylateddomains
(21) and some Alu elements may contain discriminatory
motifs associated with methylation-resistant CpG islands
(52). Somatic cells show unstable epigenetic proﬁles in
repetitive elements as demonstrated by global measure-
ments of either DNA methylation (18,20,40,41) or histone
modiﬁcations (53,54). Recent studies have revealed
interindividual variability in DNA methylation proﬁles
Nucleic Acids Research,2008, Vol. 36,No. 3 779at speciﬁc Alu elements (55), and Fraga and colleagues
detected epigenetic changes arising during the lifetime
of monozygotic twins in Alu elements and other
sequences (56).
Beyond these few studies, the extension and nature
of the epigenetic state of interspersed elements is largely
unknown. Global estimates of DNA methylation in
repetitive elements have been obtained by Southern blot
Figure 7. (A) Detail of the AUMA ﬁngerprints generated from ﬁve normal–tumor sample pairs. The presence of the Aq3 band is indicated by an
asterisk under the three Aq3 positive cases. (B) The relative position of the AUMA Aq3 band, MLT1A and Alu Y repetitive elements, as well as
MYOM2 ninth exon are shown. Each vertical line in the CpG distribution represents a CpG dinucleotide along the DNA sequence. Two diﬀerent
fragments were ampliﬁed for the bisulﬁte sequencing analysis (gray boxes). Sequence is oriented 50–30 in regard to MYOM2 30 end. (C) Methylation
status of the CpG nucleotides in the two fragments ampliﬁed were ascertained by direct sequencing of bisulﬁte-treated DNAs of 5 normal–tumor
pairs and 5 colon cancer cell lines. (D) ChIP analysis of the AluY element frequently hypomethylated in cancer revealed loss of trimethylation in
histone 3 lysine 9 residue (3mH3K9) in LoVo cells (unmethylated at DNA level) as compared to HCT116 (methylated at DNA level). Treatment of
HCT116 cells with 5AzaC and TSA produced a moderate decrease in the levels of trimethylation in H3K9.
780 Nucleic Acids Research, 2008, Vol. 36, No. 3analyses (30) and, more recently, by using approaches
based on bisulﬁte conversion of the unmethylated cytosine
(40,41,57). These studies have conﬁrmed the global
hypomethylation of most tumors but they do not provide
detailed information on the nature and localization of the
unmethylated elements. In silico analysis has revealed that
a number of Alu elements close to CpG islands retain a
high proportion of CpG sites, and this is presumed to be
a sign of unmethylation (58), but no experimental proof
has been provided. In our point of view, the lack of
simple, speciﬁc and sensitive methodologies to screen for
epigenetic changes in repetitive elements on the genomic
scale has precluded a clearer understanding of the nature
and implications of these sequences in cell biology.
Properties of QUMA and AUMA
Here we report a systematic screening of unmethylated
Alus as a tool to determine the extent of DNA hypo-
methylation, to identify speciﬁcally unmethylated ele-
ments and to detect epigenetic alterations in cancer cells.
QUMA is a very simple and speciﬁc method and provides
accurate relative estimates of the number of unmethylated
elements. QUMA is specially appropriate for compara-
tive studies, but also provides a raw quantitation of the
number of unmethylated elements per haploid genome,
outlining the extent of hypomethylated Alu’s in normal
and pathologic cells. QUMA analysis indicates that about
1 out of 6 Alu elements containing the AACCCGGG
site are unmethylated, while in tumors, this ﬁgure nearly
doubles in agreement with previous studies (23). Although
these analyses are likely to generate good estimates at the
comparative level (between samples), absolute values
should be treated with caution because the determination
refers to a single CpG site within the Alu element.
To date there is still a lack of proper methodologies
allowing genome-wide screenings for recurrent hypo-
methylated regions that may have some impact on
tumor biology. Even though QUMA and other method-
ologies (41,59) allow quantitation of unmethylated
repeats, they do not provide a straightforward approach
to identify and map the ampliﬁed targets. At this point,
AUMA takes us a step further, allowing the undoubtful
identiﬁcation of hypomethylated sequences, in addition
to hypermethylated targets. Although AUMA is specially
suited to determine the nature of the unmethylated
elements, it also allows the calculation of global unmethy-
lation in Alu elements. Nevertheless, it should be taken
into account that this is an indirect measure, because it
relies in the extent of methylation in CpG islands and
other sequences. Moreover, unmethylation of a second
SmaI site near the Alu is also required to generate the
AUMA band and hence to be detected. While AUMA
shares many technical steps with other techniques, namely
MCA (60) and AIMS (43), its design is conceptually
unique since AUMA scans for the atypically unmethy-
lated Alu sequences, unlike the other approaches that are
enriched for typical methylated sequences.
Due to sequence degeneration, both QUMA and
AUMA are more eﬀective in screening for unmethylation
in younger elements. This trend is more clearly seen
in AUMA, with only 9% of the Alu elements of the old J
subfamily containing the SmaI site retain the AA dinu-
cleotide needed for their ampliﬁcation, while this ﬁgure is
91 and 80% in the younger AluY and AluS subfamilies,
respectively (Table 1), making clear that younger Alu
elements tend to retain the SmaI site nearly as much as
they retain the AA dinucleotide required for their ampli-
ﬁcation. This bias is not a handicap, since unmethylated
Alu sequences revealed by AUMA are likely to represent
the most relevant events of this kind, because spurious
unmethylation of old Alu elements retaining a single or a
few CpG sites is expected to have less biological signif-
icance than unmethylation of younger Alu elements that
are usually closer to active chromatin regions (21) and
retain more CpGs. The stronger methylation pressure
observed in the AluY class is consistent with this
postulate.
AUMA was designed to amplify DNA fragments
containing the target sequence (AACCCGGG), which is
present in Alu and other repetitive elements. Because a
single primer was used for PCR ampliﬁcation, the target
sequence must appear in both strands of the DNA at
relatively nearby positions. As expected, Alu elements,
with more than one million copies per human genome
(15), were the most frequent repeat in AUMA bands
(50% in sequences isolated from non-tumor tissue), but
only two sequenced bands contained two inverted Alu
repeats (Supplementary Table 1). This observation is
in concordance with previous works reporting on the
instability of this inverted repeats, which might have
caused their exclusion from the human genome (61,62).
More restrictive conditions to select for Alu, or any other
repeat of interest, may be achieved by extending the 30 end
of the primer speciﬁc sequence (see Supplementary Data);
however, the number of sequences we obtained was consi-
dered appropriate to accomplish the original aim of the
study which is to screen for diﬀerentially methylated
repetitive elements in colorectal cancer.
It is worth noting that AUMA patterns are highly
reproducible not only in replicates but also among diﬀer-
ent samples, which indicates that the unmethylated status
of these repeats is tightly controlled, probably by the
epigenetic status of nearby regions. This is strengthened by
the conﬁrmation that unmethylation extends many CpG
sites beyond the SmaI cut site. Moreover, about 50% of
the bands tagged in AUMA ﬁngerprints exhibited variable
display among normal tissues (data not shown), suggest-
ing the usefulness of this technique to investigate epigene-
tic polymorphisms.
Alu’s and other repetitive elements tend to be highly
methylated in most somatic tissues (8,9,40,63). Here we
have identiﬁed 78 ‘atypical’ Alu elements exhibiting
full or partial unmethylation in normal colonic mucosa
cells. Diﬀerent evidences underscore the adequacy of this
approach to track changes with possible functional impli-
cations: (i) a signiﬁcant portion of the characterized bands
are located inside or nearby CpG islands and genes;
(ii) AUMA products show a characteristic distribution
in R bands, coincidentally with the distribution of Alu
sequences (15), indicating a bias toward the gene-richest
portion of the genome known as the H3 isochore (64).
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Alu families showed striking diﬀerences in their methyla-
tion level. Most of the Alu elements characterized here are
from the younger families AluS and AluY (74% and 22%,
respectively). Nevertheless, this observation is mainly due
to the depletion of CpG sites in older Alu elements.
Hence, only 1 out 230 AluJ elements maintains the
AUMA target site (AACCCGGG), while younger ele-
ments show higher rates of maintenance in accordance
with their age (AluS: 1 out of 7; AluY: 2 out of 5)
(Table 1). Interestingly, the rate of unmethylation is higher
in older elements (AluJ: 12.2%; AluS: 3.1%; AluY: 1.6%)
(Table 1). As noted by Rollins et al. (21), the boundaries
of unmethylated domains tend to be occupied by methy-
lated Alu transposons of the younger AluS and AluY
families. Other studies have noted that CpG island-
associated Alu’s retain a higher proportion of CpG sites,
suggesting that these elements are unmethylated in the
germ line (58). These unmethylated elements that can be
easily revealed by AUMA are likely to play a regulatory
role in a signiﬁcant number of genes (65). AUMA of
tumors was enriched in Alu sequences as compared with
normal tissue (41% versus 29%, respectively), suggesting
a favored hypomethylation of Alu elements within the
global genomic hypomethylation associated with tumor-
igenesis (23).
Application ofAUMA to detect epigenetic changes
incancer cells
Cancer-related hypomethylation is well documented (23)
and diﬀerent studies have demonstrated the demethylation
of Alu’s and other repetitive elements in diﬀerent types
of neoplasias (66). Our data are consistent with previous
estimates and go one step forward in the characterization
of unmethylated repeats. The AUMA approach was
conceived as a straightforward DNA methylation screen-
ing strategy targeting speciﬁc interspersed repeats and
suitable to be applied to large series of samples or
experimental conditions as reported here.
The application of AUMA to a series of colorectal
carcinomas and their paired matched normal tissue has
revealed a high rate of alterations. This indicates the
plasticity of epigenetic control of the elements screened
by AUMA in colorectal carcinogenesis. Although some
bands show bidirectional changes (hypomethylations and
hypermethylations), which have been also reported in
other sequences (42,67), most bands display an alternative
trend either toward hypermethylations or hypomethyla-
tions. Some of these changes are highly recurrent (in more
than 50% of tumors), suggesting that they may represent
relevant alterations related to mechanisms frequently
disturbed in colon cancer. Because the default status of
repetitive elements is methylation, hypomethylations
are readily detected as the emergence of a new band in
the tumor AUMA ﬁngerprint. Since all ampliﬁed bands
include a unique sequence, it has been possible to identify
all of the isolated bands and pinpoint them in the
genomic map.
As an example, we have investigated the Aq3 sequence,
one of the most recurrent hypomethylations in this study.
Aq3 band is ﬂanked by two repeats, a LTR and an
AluY, which map within an intron between exons 8 and
9 of the MYOM2 gene at 8p23.3. Both elements are
heavily methylated in normal tissue and partially to fully
unmethylated in tumor tissue. Interestingly, we have
found moderately high levels of the heterochromatin
associated mark 3mH3K9 in the fully methylated AluYd3
element in the HCT116 cell line, while the levels were
signiﬁcantly lower (3.5-fold) in the partially demethylated
LoVo cell line. Furthermore, none of the classical active
marks AcH3K9/K14 and 2mH3K79, have been found
enriched in the LoVo cell line. These data are in concor-
dance with preliminary data showing that the hypomethy-
lation does not aﬀect the expression of MYOM2 (data not
shown) but could rather aﬀect chromatin structure in the
region. In agreement with these observations, this genomic
region undergoes frequent losses (68–70) and is rearranged
in many diﬀerent types of tumors (71,72), which hints at
a role for DNA hypomethylation in genomic instability
(24–27,73). The speciﬁc functional consequences of this
hypomethylation deserve further investigations.
Another application of AUMA is the detection of
genomic regions that have been silenced in cancer. Inter-
spersed elements are concentrated in gene-rich regions and
due to the intended selection of unmethylated repetitive
elements in AUMA, it appears reasonable to postulate
that normally unmethylated sequences are likely to pin-
point active genomic regions. In this context, AUMA
provides a large collection of genomic regions undergoing
hypermethylation, which are readily seen as bands recur-
rently loss in the ﬁngerprints. DNA methylation asso-
ciated epigenetic silencing is probably one of the most
prevalent mechanisms of tumor suppression inactivation
in cancer (33,37,74). Therefore, AUMA can also be used
to screen for diﬀerential methylation not only in Alu
elements but also in unique sequences and repetitive
elements other than Alu.
In summary, QUMA and AUMA methodologies are
a simple and novel approach to explore and gain insights
into the functional signiﬁcance of interspersed genomic
elements and neighboring sequences. Due to its distinctive
features (bias for unmethylated elements in gene-rich
regions and detection of both hypomethylation and hyper-
methylation) we think that these techniques constitute
a new and unique tool that should complement global
determinations and high-resolution genome-wide scanning
strategies. Beyond unmethylated repetitive elements,
AUMA can be also used to detect recurrent epigenetic
changes associated with tumorigenesis including gene
epigenetic inactivation.
SUPPLEMENTARY DATA
Supplementary data are available at NAR Online.
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